Pulmonx (LUNG) Asset Writedowns and Impairment (2019 - 2025)
Pulmonx (LUNG) posted quarterly Asset Writedowns and Impairment of $72000.0 for Q3 2025, up 149.32% year-over-year from $28879.1 in Q3 2024, and up 244.0% quarter-over-quarter from -$50000.0 in Q2 2025.
Pulmonx (LUNG) Asset Writedowns and Impairment (2019 - 2025) Analysis & Trends
Pulmonx (LUNG) has reported Asset Writedowns and Impairment for 7 consecutive years, with $72000.0 the latest figure, recorded in Q3 2025.
- In Q3 2025, Asset Writedowns and Impairment rose 149.32% year-over-year to $72000.0; the TTM figure through Sep 2025 stood at -$24000.0 (down 101.83% YoY), while the FY2024 annual figure was $1.7 million, up 238.66% from the prior year.
- Asset Writedowns and Impairment grew to $72000.0 in Q3 2025 per LUNG's latest filing, from -$50000.0 in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $1.7 million in Q2 2024 and bottomed at -$405000.0 in Q4 2023.
- Historically, Asset Writedowns and Impairment has averaged $215055.6 across 5 years, with a median of $166500.0 in 2022.
- Annual changes were most pronounced in 2023 — Asset Writedowns and Impairment plunged 338.24% — and 2024, when it soared 1488.79%.
- Pulmonx's Asset Writedowns and Impairment stood at $214000.0 in 2021, then fell by 20.56% to $170000.0 in 2022, then slumped by 338.24% to -$405000.0 in 2023, then soared by 63.95% to -$146000.0 in 2024, then jumped by 149.32% to $72000.0 in 2025.
- Business Quant data shows LUNG's Asset Writedowns and Impairment at $72000.0 in Q3 2025, -$50000.0 in Q2 2025, and -$46000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.07 Bn | 193.46 Bn | 7.27 Bn |
| 2 | Stryker | 127.90 Bn | 124.43 Bn | 4.50 Bn |
| 3 | Medtronic | 118.84 Bn | 109.62 Bn | 6.41 Bn |
| 4 | Boston Scientific | 73.33 Bn | 72.79 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.93 Bn | 47.68 Bn | 1.35 Bn |
| 6 | Dexcom | 34.46 Bn | 32.51 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.91 Bn | 31.81 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.36 Bn | 23.04 Bn | 4.55 Bn |
| 9 | Steris | 23.12 Bn | 22.64 Bn | 684.20 Mn |
| 10 | Pulmonx | 93.78 Mn | 24.03 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 72,000.00 |
| Sep 30, 2025 | 72,000.00 |
| Jun 30, 2025 | -50,000.00 |
| Jun 30, 2025 | -50,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Mar 31, 2025 | -46,000.00 |
| Sep 30, 2024 | -146,000.00 |
| Sep 30, 2024 | -146,000.00 |
| Jun 30, 2024 | 1.70 Mn |
| Jun 30, 2024 | 1.70 Mn |
| Mar 31, 2024 | 163,000.00 |
| Mar 31, 2024 | 163,000.00 |
| Dec 31, 2023 | -405,000.00 |
| Dec 31, 2023 | -405,000.00 |
| Sep 30, 2023 | 532,000.00 |
| Sep 30, 2023 | 532,000.00 |
| Jun 30, 2023 | 107,000.00 |
| Jun 30, 2023 | 107,000.00 |
| Mar 31, 2023 | 273,000.00 |
| Mar 31, 2023 | 273,000.00 |